You just read:

GHIT Fund Announces New Investments: A Total of 2.86 Billion Yen in Drug for Schistosomiasis, Dengue, Malaria and Tuberculosis, Vaccines for Leishmaniasis and Malaria, and Diagnostics for Tuberculosis

News provided by

Global Health Innovative Technology (GHIT) Fund

Mar 27, 2019, 21:00 ET